🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ALL THE GREAT CIVILIZATIONS OF THE ANCIENT WORLD LOOKED TO GREATER CIVILIZATIONS LONG BEFORE THEM None of the great ancient civilizations, whether Egypt, Mesopotamia, India, China, Mesoamerica, Peru etc. claimed to be the first. All spoke of an older higher civilization,

#ASCO25: In pts with 5–20 brain mets, Phase 3 trial shows SRS/SRT leads to significantly better QoL vs HA-WBRT (↓ symptoms & interference, p<0.001), with no OS difference (8.3 vs 8.5 mo). SRS/SRT should be new SoC in this setting. #radonc 🔗 meetings.asco.org/abstracts-pres…

Cervical cancer kills 350 000 women each year, and another 600 000 are diagnosed. Yet it could become the first cancer in history to be eliminated, thanks to HPV vaccines and timely screening and treatment. That is why I made a Call to Action in 2018. I’m so inspired by the

Oncologists Arriving at ASCO Returning from ASCO #ASCO25

Best of #ASCO25 - LMIC version 1. CHALLENGE - Exercise for Resected colon ca survivors post chemo 2. Chronoimmunotherapy 3. 15-year SOFT and TEXT update 4. Ultra-low-dose I/O for solid tumors in relapsed/refractory setting OncoAlert #bcsm #lcsm #crcsm #Immunotherapy

Busting food safety 🛡️ myths this #WorldFoodSafetyDay!

How to select pts with HCC for various local therapies? RFA ,MWA , TACE , SIRT , SBRT . Useful for clinical decision-making. Taken from #asco25 ASCO Do u agree ? Yakup Ergün Dr. Nina Niu Sanford Jeff Ryckman OncoAlert Kate Sears

Initiating fecal immunochemical test screening for colorectal cancer at ages 40 to 49 leads to reductions in colorectal cancer mortality and incidence. ja.ma/45mHxGm

The Beauty of Wildlife ~ A Thread 🧵 1. An elephant family is sleeping photographed by a drone…

🧬 A rare & inherited cancer, finally getting attention. 📌 18 June 25 NEJM presents: Bevacizumab + Erlotinib in HLRCC-related pRCC 🔹 ORR: 72% 🔹 Median PFS: 21.1 mo 🔹 Median OS: 44.6 mo 🔗 nejm.org/doi/full/10.10… A breakthrough in an ultra-rare, treatment-resistant

DA-EPOCH-R ⬆️outcomes in HGBCL-DH-BCL2 vs historic R-CHOP 2-yr TTP 71% vs 47%,p=0.02 2-yr OS 75% vs 47%, p=0.008 OS worse in DZsig⁺ but still > historic MYC partner not prognostic IPI-adjusted HR 0.38 for both TTP & OS. Still no RCTs, but evidence is mounting. #ICML2025 #lymsm

How to interpret p-values 😅

Viewpoint: Prostate cancer screening is shifting toward a more beneficial and less harmful approach by using MRI-targeted strategies, which reduce unnecessary biopsies and overdiagnosis. ja.ma/45rVOSb Ivo Schoots

Lean body mass–based oxaliplatin dosing reduces peripheral neuropathy in stage III colon cancer without compromising survival! ✅ Lower rates of grade ≥2 oxaliplatin-induced peripheral neuropathy ✅ Better quality of life ✅ No impact on relapse-free survival or overall survival

Lazertinib vs Osimertinib in Previously Untreated EGFR-mutant Advanced NSCLC: A Randomized, Double-blind, Exploratory Analysis From MARIPOSA 🦋👇 JTO 2025 OncoAlert jto.org/article/S1556-…

🚨A fantastic review for non-clear cell renal cell carcinoma! in Nature Reviews Urology 👉Time to tailor, not generalize: 🔬 Genotype-driven subtyping (e.g. MET, FH, TSC-mTOR, ALK, MITF, SMARCB1) enables precision therapy. 💊 Cabozantinib & savolitinib show promise in MET-driven tumors.

Ha ha ha

Def true 4 me 😮‍💨

BREAKING: ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.